New Cancer Study Findings Have Been Reported from Hannam University (Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy).

A recent study from Hannam University in South Korea explores the development of antibody-drug conjugates (ADCs) for cancer therapy. The researchers discuss the evolution of ADCs, which are designed to target cancer cells while minimizing harm to healthy cells. The study provides an overview of 12 available ADCs, reviews 71 research papers, and analyzes 128 clinical trial reports. The goal is to gain insights into current trends in ADC research and development, with a focus on emerging frontiers in cancer treatment. [Extracted from the article]